Pricing variations between early access prices and list prices in Switzerland

Previous PostUnderstanding the burden of aromatic L-amino acid decarboxylase deficiency (AADCd): Results from a clinician expert survey
Next PostIncreased legal certainty surrounding medicine discounting may increase Switzerland's attractiveness as an early launch country